IQVIA Holdings Inc. (LON:0JDM)
London · Delayed Price · Currency is GBP · Price in USD 230.17
-6.05 (-2.56%)
At close: Jan 30, 2026
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of 28.57 billion as of January 30, 2026. Its market cap has decreased by -1.77% in one year.
Market Cap
28.57B
Enterprise Value
38.33B
Revenue
11.83B
Ranking
n/a
PE Ratio
29.93
Stock Price
230.17
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from 3.50B to 28.57B, an increase of 715.73%. That is a compound annual growth rate of 17.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 28.57B | 0.17% |
| Dec 31, 2025 | 28.52B | 0.11% |
| Dec 31, 2024 | 28.49B | -14.06% |
| Dec 29, 2023 | 33.15B | 4.96% |
| Dec 30, 2022 | 31.58B | -20.65% |
| Dec 31, 2021 | 39.81B | 58.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.75B |
| GSK plc | 74.30B |
| Haleon | 33.10B |
| Smith & Nephew | 10.31B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.36B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.88B |